Updated:
Frontline BioVentures
Frontline BioVentures is a venture capital based in Hong Kong; the Altss profile covers its classification, headquarters, registration, AUM band, and key...
Frontline BioVentures
Frontline Bioventures (Hong Kong) Limited is an exempt reporting adviser in Hong Kong. It operates from Hong Kong.
General information
Firm type
Venture Capital
Location
Region
Asia
Country
Hong Kong
City
Hong Kong
Corporate office
Hong Kong
Sector focus
Frequently asked questions
What is Frontline BioVentures?
Frontline BioVentures is a venture capital headquartered in Hong Kong, Hong Kong.
Where is Frontline BioVentures headquartered?
Frontline BioVentures is headquartered in Hong Kong, Hong Kong, in the Asia region.
What does Altss track for Frontline BioVentures?
Altss maintains an OSINT-verified profile of Frontline BioVentures covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What type of firm is Frontline BioVentures?
Frontline BioVentures is classified by Altss as a Venture Capital, operating from Hong Kong within the Asia region.
How does Altss source intelligence on Frontline BioVentures?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Frontline BioVentures's Altss profile last updated?
Frontline BioVentures's profile on Altss was last refreshed on August 14, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: